Broad microbial and viral targets

The term 'Broad microbial and viral targets' refers to a non-specific category of biological structures and pathways found across a wide range of pathogenic organisms, including viruses, bacteria, and fungi. It does not represent a single molecular entity, such as a specific receptor or enzyme, but rather a collective group of potential therapeutic sites (Santos et al., 2017). Examples of specific targets that might fall under this umbrella include viral proteases, bacterial RNA polymerases, or fungal cell wall components. Because the term is so broad, it encompasses a vast diversity of biological functions, from genomic replication to structural integrity. In clinical practice, drugs that hit multiple targets within this category are often referred to as broad-spectrum antimicrobials or antivirals (CDC, 2022). However, for the purposes of drug discovery and molecular pharmacology, this designation is considered too vague to be a valid therapeutic target. Precise identification of a specific protein or nucleic acid is required to understand the mechanism of action and safety profile of a candidate drug (Hopkins & Groom, 2002).

Other names

Broad-spectrum anti-infective targetsMulti-pathogen targetsNon-specific antimicrobial targets

Not applicable as this is a collective category rather than a specific molecular target.